Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linz

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbitsO Jung, H C Englert, W Jung, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1992
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillariesT Unger, T Mattfeldt, V Lamberty, et al.
Journal of Rehabilitation and Assistive Technologies Engineering|June 14, 2019
Monitoring hemodynamic changes in stroke-affected muscles using near-infrared spectroscopyMohammad MasoudiMotlagh, Jeffrey J Sugar, Mehdi Azimipour, et al.
Journal of Medicinal Chemistry|September 17, 1993
Renin inhibitors containing a pyridyl amino diol derived C-terminusH Heitsch, R Henning, H W Kleemann, et al.
British Journal of Pharmacology|June 1, 1993
Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemiaW Scholz, U Albus, H J Lang, et al.
Cardiovascular Research|February 1, 1995
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusionW Scholz, U Albus, L Counillon, et al.
Biomedica Biochimica Acta|January 1, 1988
Synthesis and biological activity of new leukotriene antagonists (racemates and enantiomerically pure compounds)C Anagnostopulos, W Bartmann, G Beck, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1993
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphateP Gohlke, V Lamberty, I Kuwer, et al.
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen speciesS Wassmann, U Laufs, A T Bäumer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1988
Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166J Striessnig, E Meusburger, M Grabner, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 14, 2000
The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbitsO Jung, H C Englert, W Jung, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1992
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillariesT Unger, T Mattfeldt, V Lamberty, et al.
Journal of Rehabilitation and Assistive Technologies Engineering|June 14, 2019
Monitoring hemodynamic changes in stroke-affected muscles using near-infrared spectroscopyMohammad MasoudiMotlagh, Jeffrey J Sugar, Mehdi Azimipour, et al.
Journal of Medicinal Chemistry|September 17, 1993
Renin inhibitors containing a pyridyl amino diol derived C-terminusH Heitsch, R Henning, H W Kleemann, et al.
British Journal of Pharmacology|June 1, 1993
Hoe 694, a new Na+/H+ exchange inhibitor and its effects in cardiac ischaemiaW Scholz, U Albus, H J Lang, et al.
Cardiovascular Research|February 1, 1995
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusionW Scholz, U Albus, L Counillon, et al.
Biomedica Biochimica Acta|January 1, 1988
Synthesis and biological activity of new leukotriene antagonists (racemates and enantiomerically pure compounds)C Anagnostopulos, W Bartmann, G Beck, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1993
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphateP Gohlke, V Lamberty, I Kuwer, et al.
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen speciesS Wassmann, U Laufs, A T Bäumer, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1988
Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166J Striessnig, E Meusburger, M Grabner, et al.
Pageof 11